ENTITY
Shanghai Haoyuan Chemexpress C

Shanghai Haoyuan Chemexpress C (688131 CH)

17
Analysis
Health Care • China
Shanghai Haoyuan Chemexpress Co., Ltd. manufactures and distributes small molecule drugs. The Company produces molecular block and pharmaceutical tool compounds and provides contract research organization, chemical manufacturing and control, and contract development manufacture organization services. Shanghai Haoyuan Chemexpress serves clients across worldwide.
more
•06 Aug 2026 23:34

Primer: Shanghai Haoyuan Chemexpress C (688131 CH) - Aug 2026

Shanghai Haoyuan Chemexpress is a rapidly growing Contract Research, Development, and Manufacturing Organization (CRDMO) capitalizing on the...

Share
bullish•Quantitative Analysis
•24 May 2026 10:15

A-Share Margin Trading Weekly (May 22nd): JIANGSU XINQUAN AUTOMOTIVE TRIM, LENS TECHNOLOGY, BOE

We analyzed A-share margin trading positions report for the past week and highlighted JIANGSU XINQUAN AUTOMOTIVE TRIM, LENS TECHNOLOGY, BOE,...

Logo
128 Views
Share
•27 Oct 2025 16:50

Quiddity Leaderboard CSI Medical Dec25: New Expected DEL Due to Liquidity; US$345mn One-Way

Harbin Fuerjia Tech (301371 CH) appeared in our leaderboard for the first time in October 2025 (this insight). We currently have this as an...

Share
•22 Sep 2025 15:33

Quiddity Leaderboard CSI Medical Dec25: Some Changes to Expected ADDs/DELs; US$362mn One-Way

We estimate the CSI Medical December 2025 index rebalance to trigger flows of ~US$362mn one-way. On average, the expected DELs have higher impact...

Share
bearish•XtalPi
•04 Jun 2024 08:55

Pre-IPO QuantumPharm (PHIP Updates) - Some Points Worth the Attention

QuantumPharm's business model struggle to scale revenue solely through service fees. Profitability is a pain point for AI pharmaceutical companies....

Logo
753 Views
Share
x